Emmett Brennan

242 posts

Emmett Brennan banner
Emmett Brennan

Emmett Brennan

@EBrennan9

Cardiology Fellow - Maimonides Medical Center, Previously: IM resident @ OBH & BST trainee at MMUH . MRCPI 🇮🇪, Quod scripsi, scripsi....

Ireland Katılım Ekim 2010
358 Takip Edilen193 Takipçiler
Emmett Brennan retweetledi
Jasmine Sethi
Jasmine Sethi@JasmineNephro·
✅SGLT2 inhibitor Prescription ⏬ 🫡Sick day rule-Stop SGLT2 when pt unwell (fever/vomiting/diarrhea)-Pt education must👍
Jasmine Sethi tweet media
English
0
99
420
50.1K
Emmett Brennan retweetledi
Physics In History
Physics In History@PhysInHistory·
An expert is a person who has made all the mistakes that can be made in a very narrow field. – Niels Bohr
Physics In History tweet media
English
106
1.5K
8.4K
468.2K
Emmett Brennan retweetledi
Saad Ur Rahman
Saad Ur Rahman@SaadUrRahman55·
Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart transplantation, HF hospitalizations, outpatient worsening HF events.
English
14
207
552
167K
Emmett Brennan retweetledi
Eric Topol
Eric Topol@EricTopol·
People with 2 copies of APOE4 have ~10X risk of Alzheimer's. Here's the discovery of a protective variant and learning how fibronectin 1 plays a role link.springer.com/article/10.100…
English
4
142
515
116.2K
Emmett Brennan retweetledi
Dr Shailesh Singh
Dr Shailesh Singh@drShaileshSingh·
Recent advances in Cardiology. (For residents, fellows and professionals in Cardiology) #CardioTwitter #cardioEd All the trials presented at #ACC2024
English
6
100
304
85.1K
Emmett Brennan
Emmett Brennan@EBrennan9·
Had a fantastic experience at #ACC2024. A wide range of educational sessions on all things cardiology. Came away with ideas for ideas for future research projects #acc #acc2024 #ACCFIT
Emmett Brennan tweet mediaEmmett Brennan tweet mediaEmmett Brennan tweet mediaEmmett Brennan tweet media
English
1
1
9
1.1K
Emmett Brennan retweetledi
Davide Capodanno
Davide Capodanno@DFCapodanno·
Over the last three days, we’ve seen almost all pharmacological strategies presented at #ACC24 fail, including beta blockers, which seemed like the only certainty. On the contrary, if we are to believe in the results we've seen, we should start using more microaxial flow pump devices in STEMI-related cardiogenic shock, doing PCI in vulnerable plaques, and TAVI in low-risk patients. Perhaps a bit too much excitement for interventionalists all at once, wasn't it better to distribute it a bit more throughout the year?
Davide Capodanno tweet media
English
11
53
224
29.6K
Emmett Brennan retweetledi
C. Michael Gibson MD
C. Michael Gibson MD@CMichaelGibson·
ULTIMATE DAPT trial showed in pts with ACS treated with PCI, ticagrelor monotherapy btw 1 and 12 months decreased clinically-relevant and major bleeding, had similar protection from MACCE vs DAPT (ticagrelor + aspirin).
C. Michael Gibson MD tweet mediaC. Michael Gibson MD tweet media
English
1
57
148
12.5K
Emmett Brennan
Emmett Brennan@EBrennan9·
Fascinating session making a case for restructuring the guidelines for High Risk PE based on evolving catheter based options and mechanical support. Systemic thrombolysis study enrolled 8 patients -> class 1b recommendation. ……Wild. #ACC2024
Emmett Brennan tweet media
English
0
0
4
220
Emmett Brennan retweetledi
NEJM
NEJM@NEJM·
Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
NEJM tweet media
English
4
313
613
322.1K
Vince™
Vince™@Blue_Footy·
...but Liverpool fielded kids 🤔. People believe what they want to believe. At this point, everyone is trying to use anything against us, including lies. But facts don't lie.
Vince™ tweet media
English
519
1.2K
8.6K
428.1K
Emmett Brennan retweetledi
Emmett Brennan retweetledi
Nikhil Narang, MD
Nikhil Narang, MD@Nikhil15·
Really nice new paper in @JACCJournals led by @StanSwatMD @kofi_larry on reasons for nonintensification of indicated GDMT in outpatients with HFrEF Should dedicated “GDMT” clinics (PharmD/APN/MD) be established with the purpose being to ⬇️ inertia? 📎 tinyurl.com/y6syewns
Nikhil Narang, MD tweet media
English
2
13
48
5.4K